{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:40:17Z","timestamp":1790692817972,"version":"4.1.0"},"reference-count":51,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mmr.2017.6484","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T11:09:51Z","timestamp":1492600191000},"page":"3615-3622","source":"Crossref","is-referenced-by-count":67,"title":["Anti-inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells"],"prefix":"10.3892","volume":"15","author":[{"given":"Ailing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"key20180108015839_b1-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key20180108015839_b2-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-016-0928-y","article-title":"Co-morbidity in patients with early rheumatoid arthritis-inflammation matters","volume":"18","author":"Innala","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"key20180108015839_b3-mmr-15-06-3615","first-page":"491974","article-title":"Natural killer cells and their role in rheumatoid arthritis: Friend or foe?","author":"Shegarfi","year":"2012","journal-title":"ScientificWorld Journal"},{"key":"key20180108015839_b4-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.145.12.4154","article-title":"Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization","volume":"45","author":"MacNaul","year":"1990","journal-title":"J Immunol"},{"key":"key20180108015839_b5-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1756-185X.12132","article-title":"Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis","volume":"16","author":"Azizi","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"key20180108015839_b6-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"key20180108015839_b7-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180108015839_b8-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180108015839_b9-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"key20180108015839_b10-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3083.1999.00581.x","article-title":"Change in the Th1\/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium","volume":"50","author":"Aarvak","year":"1999","journal-title":"Scand J Immunol"},{"key":"key20180108015839_b11-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"key20180108015839_b12-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.imlet.2009.10.006","article-title":"IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients","volume":"127","author":"Heo","year":"2010","journal-title":"Immunol Lett"},{"key":"key20180108015839_b13-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaci.2009.04.003","article-title":"Development and function of TH17 cells in health and disease","volume":"123","author":"Louten","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"key20180108015839_b14-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00296-009-0949-9","article-title":"Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica","volume":"30","author":"Dejaco","year":"2010","journal-title":"Rheumatol Int"},{"key":"key20180108015839_b15-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in Arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"key20180108015839_b16-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000036","article-title":"T cell subsets and their role in the pathogenesis of rheumatic disease","volume":"26","author":"Gizinski","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"key20180108015839_b17-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"751793","DOI":"10.1155\/2015\/751793","article-title":"Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications","volume":"2015","author":"Alunno","year":"2015","journal-title":"Mediators Inflamm"},{"key":"key20180108015839_b18-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/ard.2009.126573","article-title":"Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA","volume":"69","author":"Nam","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key20180108015839_b19-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"key20180108015839_b20-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1572-0241.2007.01545.x","article-title":"The David Y. Graham lecture: Use of nonsteroidal antiinflammatory drugs in a COX-2 restricted environment","volume":"103","author":"Chan","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20180108015839_b21-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"68","DOI":"10.20452\/pamw.3271","article-title":"Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti-inflammatory drugs. A summary of guidelines from an international expert group","volume":"126","author":"Mosleh","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"key20180108015839_b22-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"key":"key20180108015839_b23-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"key20180108015839_b24-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/1471-2474-15-389","article-title":"The rheumatoid arthritis treat-to-target trial: A cluster randomized trial within the Corrona rheumatology network","volume":"15","author":"Harrold","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"key20180108015839_b25-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key20180108015839_b26-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180108015839_b27-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1254\/jphs.08256FP","article-title":"The Efficacy and Mechanism Action of RvCSd, a New herbal agent, on immune suppression and cartilage protection in a mouse model of rheumatoid arthritis","volume":"109","author":"Lee","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"key20180108015839_b28-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/srep01629","article-title":"Oxymatrine prevents NF-\u03baB nuclear translocation and ameliorates acute intestinal inflammation","volume":"3","author":"Guzman","year":"2013","journal-title":"Sci Rep"},{"key":"key20180108015839_b29-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00011-010-0300-7","article-title":"Oxymatrine reduces neuronal cell apoptosis by inhibiting Toll-like receptor 4\/nuclear factor kappa-B-dependent inflammatory responses in traumatic rat brain injury","volume":"60","author":"Dong","year":"2011","journal-title":"Inflamm Res"},{"key":"key20180108015839_b30-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1590\/S0102-865020150060000008","article-title":"Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2\/HO-1 pathway","volume":"30","author":"Jiang","year":"2015","journal-title":"Acta Cir Bras"},{"key":"key20180108015839_b31-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1142\/S0192415X14500888","article-title":"In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B","volume":"42","author":"Yao","year":"2014","journal-title":"Am J Chin Med"},{"key":"key20180108015839_b32-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.3892\/mmr.2015.3977","article-title":"Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression","volume":"12","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180108015839_b33-mmr-15-06-3615","first-page":"573","article-title":"The Protective Effect of Sodium Ferulate and Oxymatrine Combination on Paraquat-induced Lung Injury","volume":"14","author":"Wang","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"key20180108015839_b34-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3892\/mmr.2015.3338","article-title":"Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo","volume":"11","author":"Wu","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180108015839_b35-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1381612822666151112152733","article-title":"Antiviral natural products against chronic hepatitis B: Recent Developments","volume":"22","author":"Parvez","year":"2016","journal-title":"Curr Pharm Des"},{"key":"key20180108015839_b36-mmr-15-06-3615","first-page":"329","article-title":"Aquatic environment, housing and management in the eighth edition of the guide for the care and use of laboratory animals: Additional considerations and recommendations","volume":"51","author":"Mason","year":"2012","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"key20180108015839_b37-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"key20180108015839_b38-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108015839_b39-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"c6942","DOI":"10.1136\/bmj.c6942","article-title":"Recent advances in the management of rheumatoid arthritis","volume":"341","author":"Klarenbeek","year":"2010","journal-title":"Br Med J"},{"key":"key20180108015839_b40-mmr-15-06-3615","first-page":"9","article-title":"Immunodeficiency-associated Burkitt lymphoma developed in a patient receiving a long-term methotrexate therapy for rheumatoid arthritis","volume":"57","author":"Katsuragi","year":"2016","journal-title":"Rinsho Ketsueki"},{"key":"key20180108015839_b41-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamadermatol.2015.3029","article-title":"Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer","volume":"152","author":"Scott","year":"2016","journal-title":"JAMA Dermatol"},{"key":"key20180108015839_b42-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3892\/or.2016.5292","article-title":"Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-\u03b21\/Smad signaling pathway","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol Rep"},{"key":"key20180108015839_b43-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"584303","DOI":"10.1155\/2013\/584303","article-title":"Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"2013","author":"Estrada-Capetillo","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"key20180108015839_b44-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: The third member of the effector T cell trlogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"key20180108015839_b45-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: An effector CD4 T cell lineage with regulatory T Cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"key":"key20180108015839_b46-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in Arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"key20180108015839_b47-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"e0143715","DOI":"10.1371\/journal.pone.0143715","article-title":"The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of autoimmune hepatitis","volume":"10","author":"An Haack","year":"2015","journal-title":"PLoS One"},{"key":"key20180108015839_b48-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis","volume":"31","author":"Lina","year":"2011","journal-title":"J Clin Immunol"},{"key":"key20180108015839_b49-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0394632015595757","article-title":"Altered Th17\/Treg balance and dysregulated IL-1\u03b2 response influence susceptibility\/resistance to experimental autoimmune arthritis","volume":"28","author":"Venkatesha","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20180108015839_b50-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/icb.2008.52","article-title":"Human immunodeficiency: Connecting STAT3, Th17 and human mucosal immunity","volume":"86","author":"Fischer","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"key20180108015839_b51-mmr-15-06-3615","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6484\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:05:43Z","timestamp":1750201543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,19]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mmr.2017.6484"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6484","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}